The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic Sclerosis
Systemic sclerosis (SSc) is an autoimmune connective tissue disease that leads to skin fibrosis. Altered metabolism has recently been described in autoimmune diseases and SSc. Itaconate is a product of the Krebs cycle intermediate <i>cis</i>-aconitate and is an immunomodulator. This work...
Main Authors: | John Henderson, Sharadha Dayalan Naidu, Albena T. Dinkova-Kostova, Stefan Przyborski, Richard Stratton, Steven O′Reilly |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/8/2053 |
Similar Items
-
Four-octyl itaconate activates Keap1-Nrf2 signaling to protect neuronal cells from hydrogen peroxide
by: Hua Liu, et al.
Published: (2018-11-01) -
Novel organic glass with superior optical properties based on dimethyl itaconate and diethyl itaconate
by: Yu Gao, et al.
Published: (2021-11-01) -
4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients
by: Chun Tang, et al.
Published: (2018-11-01) -
The Emerging Application of Itaconate: Promising Molecular Targets and Therapeutic Opportunities
by: Jiaqi Lin, et al.
Published: (2021-05-01) -
Integrative metabolomics and transcriptomics identifies itaconate as an adjunct therapy to treat ocular bacterial infection
by: Sukhvinder Singh, et al.
Published: (2021-05-01)